Key result
VP1-substituted recombinant virus improves capsid stability while maintaining immunogenicity vs parental strain in pigs.
Why the study?
Inactivated FMDV vaccine efficacy depends on 146S virion integrity, but the highly immunogenic Korean serotype O strain O Jincheon exhibits poor physical stability during manufacturing and storage.
Does a VP1-substituted recombinant FMDV vaccine improve capsid stability and maintain immunogenicity compared to the parental strain in pigs?
Does a VP1-substituted recombinant FMDV vaccine improve capsid stability and maintain immunogenicity compared to the parental strain in pigs?
Answers are grounded in this paper and cite their sources.
VP1-directed chimeric engineering improves the capsid stability of FMDV vaccines without compromising antigenicity.
Background/Objectives: The efficacy of inactivated foot-and-mouth disease virus (FMDV) vaccines depends on the structural integrity of the 146S virions. However, instability of 146S antigens during vaccine manufacturing and storage can compromise vaccine quality. Despite its high immunogenicity, the Korean serotype O strain O Jincheon (O JC) exhibits poor physical stability. Methods: To enhance antigenic stability while preserving strain-specific antigenicity, we engineered a VP1-substituted recombinant virus, (R) O1 M–O JC_VP1, by integrating the VP1 coding region of O JC into the O1 Manisa (O1 M) backbone. Results: The resulting chimeric virus exhibited significantly improved capsid stability, as demonstrated by an increased melting temperature and enhanced resistance to thermal stress, chloroform exposure, and long-term storage. Importantly, the recombinant antigen maintained its immunogenicity and induced antibody responses comparable to those induced by the parental O JC strain in vaccinated pigs. Conclusions: These findings demonstrate that VP1-direct chimeric engineering can improve capsid stability without compromising antigenicity and provide a practical approach for developing a stable FMDV vaccine.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied Foot-and-mouth disease virus (FMDV) vaccine development. VP1-substituted recombinant virus, (R) O1 M–O JC_VP1 vs. Parental O JC strain was evaluated on Capsid stability and immunogenicity. A VP1-substituted recombinant foot-and-mouth disease virus exhibited significantly improved capsid stability while maintaining immunogenicity comparable to the parental strain in vaccinated pigs.
Synapse has enriched 10 related papers. Consider them for comparative context: